Creative Medical Technology
CELZ
12 hedge funds and large institutions have $185K invested in Creative Medical Technology in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
9% more funds holding
Funds holding: 11 → 12 (+1)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
5.23% less ownership
Funds ownership: 7.94% → 2.71% (-5.2%)
58% less capital invested
Capital invested by funds: $437K → $185K (-$252K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
+$25.2K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$24K |
| 3 |
AF
Allworth Financial
Folsom,
California
|
+$8.6K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$5.61K |
| 5 |
AAS
Ameritas Advisory Services
Lincoln,
Nebraska
|
+$4.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$321K |
| 2 |
HF
HRT Financial
New York
|
-$28K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.57K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$282 |
| 5 |
OP
ORG Partners
Roanoke,
Indiana
|
-$160 |
CELZ Hedge Fund Activity: Q2 2025 in Review
12 of the 7,610 institutional investors tracked by Wall St. Rank reported a position in Creative Medical Technology (CELZ) for Q2 2025, worth a combined $185K — down 58% from $437K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CELZ positions and 3 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Northern Trust, opening a new position worth an estimated $25.2K. The largest seller was Armistice Capital, exiting entirely with an estimated $321K sold.
- 12 institutional investors held Creative Medical Technology (CELZ) as of Q2 2025, up from 11 in Q1 2025.
- Funds reported $185K of Creative Medical Technology stock for Q2 2025, down 58% quarter-over-quarter.
- 4 funds opened new Creative Medical Technology positions in Q2 2025 and 3 closed out, a net change of +1 holder.
- The largest Creative Medical Technology buyer in Q2 2025 was Northern Trust, an estimated $25.2K added.
- The largest Creative Medical Technology seller in Q2 2025 was Armistice Capital, an estimated $321K sold.
Based on aggregated 13F filings for Q2 2025.